RETRACTED: Generation of Haploid Spermatids on Silk Fibroin‐Alginate‐Laminin‐Based Porous 3D Scaffolds
Macromolecular Bioscience · 2023
DOI: 10.1002/mabi.202200574 ↗Kurz gefasst
Zurückgezogene Publikation in der Zeitschrift Macromolecular Bioscience, 2023. Verfasst von Zahra Bashiri und 9 weiteren Autor:innen. Beteiligte Einrichtung: Stem cell and Regenerative Medicine Research Center, Iran University of Medical Sciences, Tehran, 1449614535, Iran. Hauptthemen laut MEDLINE: Fibroins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: Iran National Science Foundation, Iran University of Medical Sciences.
Abstract (Originalsprache)
In vitro production of sperm is a desirable idea for fertility preservation in azoospermic men and prepubertal boys suffering from cancer. In this study, a biocompatible porous scaffold based on a triad mixture of silk fibroin (SF), alginate (Alg), and laminin (LM) is developed to facilitate the differentiation of mouse spermatogonia stem cells (SSCs). Following SF extraction, the content is analyzed by SDS‐PAGE and stable porous 3D scaffolds are successfully prepared by merely Alg, SF, and a combination of Alg‐SF, or Alg‐SF‐LM through freeze‐drying. Then, the biomimetic scaffolds are characterized regarding the structural and biological properties, water absorption capacity, biocompatibility, biodegradability, and mechanical behavior. Neonatal mice testicular cells are seeded on three‐dimensional scaffolds and their differentiation efficiency is evaluated using real‐time PCR, flow cytometry, immunohistochemistry. Blend matrices showed uniform porous microstructures with interconnected networks, which maintained long‐term stability and mechanical properties better than homogenous structures. Molecular analysis of the cells after 21 days of culture showed that the expression of differentiation‐related proteins in cells that are developed in composite scaffolds is significantly higher than in other groups. The application of a composite system can lead to the differentiation of SSCs, paving the way for a novel infertility treatment landscape in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stem cell and Regenerative Medicine Research Center, Iran University of Medical Sciences, Tehran, 1449614535, Iran.
- Department of Anatomy, School of Medicine, Iran University of Medical Sciences, Tehran, 1449614535, Iran.
- Omid Fertility & Infertility Clinic, Hamedan, 6516796198, Iran.
- Departement of Biomedical Engineering, Science and Research Branch, Islamic Azad University, Tehran, 1477893855, Iran.
- Immunology Research Center (IRC), Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, 1449614535, Iran.
- Department of Anatomy, School of Medicine, Shahrekord University of Medical Sciences, Shahrekord, 8815713471, Iran.
ORCID-Profile: Zahra Bashiri, Hamid Reza Asgari, Morteza Koruji
Förderung
- Iran National Science Foundation
- Iran University of Medical Sciences
Zitieren
APA
Bashiri, Z., Moghaddaszadeh, A., Falak, R., Khadivi, F., Afzali, A., Abbasi, M., Sharifi, A. M., Asgari, H. R., Ghanbari, F., & Koruji, M. (2023). RETRACTED: Generation of Haploid Spermatids on Silk Fibroin‐Alginate‐Laminin‐Based Porous 3D Scaffolds. Macromolecular Bioscience. https://doi.org/10.1002/mabi.202200574
Vancouver
Bashiri Z, Moghaddaszadeh A, Falak R, Khadivi F, Afzali A, Abbasi M, et al. RETRACTED: Generation of Haploid Spermatids on Silk Fibroin‐Alginate‐Laminin‐Based Porous 3D Scaffolds. Macromolecular Bioscience. 2023. doi:10.1002/mabi.202200574
BibTeX
@article{Bashiri2023,
author = {Bashiri, Zahra and Moghaddaszadeh, Ali and Falak, Reza and Khadivi, Farnaz and Afzali, Azita and Abbasi, Mehdi and Sharifi, Ali Mohammad and Asgari, Hamid Reza and Ghanbari, Farid and Koruji, Morteza},
title = {RETRACTED: Generation of Haploid Spermatids on Silk Fibroin‐Alginate‐Laminin‐Based Porous 3D Scaffolds},
journal = {Macromolecular Bioscience},
year = {2023},
doi = {10.1002/mabi.202200574}
}
EUVIMED